Pharmacological profiles of opioid ligands at kappa opioid receptors
Expected results: Gradual improvement in skin tone uniformity within weeks of regular use
GHK-Cu is not a growth hormone secretagogue, not an anabolic stimulant, and not a systemic endocrine amplifier
User 19 ran 500mcg twice daily for 13 weeks across a chronic multi-injury case involving a 10-year back injury and a 4-year shoulder injury, adding GHK-Cu, ipamorelin, and CJC-1295 to the protocol, and reported 90 percent pain relief after one cycle
Protein expression was analysed and detected using the Western Lightning Plus-ECL, Enhanced Chemiluminescence Substrate (PerkinElmer, NEL105001EA) and G:BOX ChemiXX6 gel doc system with GeneSys image software (Syngene)
Improve the quality of fats by eating more omega-3 fatty acids from fish and seafood, and omit inflammatory seed oils